Literature DB >> 21893976

A new endotoxin adsorber in septic shock: observational case series.

T I Ala-Kokko1, J Laurila, J Koskenkari.   

Abstract

AIMS: Effects of a new endotoxin adsorber on the length of noradrenaline (NA) treatment, LPS (lipopolysaccharide) levels and SOFA (sequential organ failure assessment) scores in septic shock were evaluated.
METHODS: Two-hour hemoperfusion with LPS adsorber was initiated in patients with septic shock and endotoxemia. Controls were matched for age, focus and severity of illness.
RESULTS: Adsorption treatment (n = 9) exhibited a significant decrease in EAA (endotoxin activity assay) activity (0.55 [0.44-0.68] vs. 0.25 [0.13-0.41], p = 0.019) and NA infusion rate (0.217 μg/kg/min [0.119-0.0508] vs. 0 μg/kg/min [0-0.09], p = 0.026) from pretreatment to 24 h post-treatment. The median decrease in SOFA scores from pretreatment to 24 h was 3.0 points (1.5-4.5), p = 0.002. Duration of NA infusion was significantly shorter compared to controls (39 h [31-48] vs. 54 h [43-151], p = 0.03).
CONCLUSIONS: LPS adsorber treatment was associated with a decrease in NA dose, decrease in SOFA scores and LPS concentrations.
Copyright © 2011 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21893976     DOI: 10.1159/000330323

Source DB:  PubMed          Journal:  Blood Purif        ISSN: 0253-5068            Impact factor:   2.614


  9 in total

Review 1.  Challenges in the management of septic shock: a narrative review.

Authors:  Daniel De Backer; Maurizio Cecconi; Jeffrey Lipman; Flavia Machado; Sheila Nainan Myatra; Marlies Ostermann; Anders Perner; Jean-Louis Teboul; Jean-Louis Vincent; Keith R Walley
Journal:  Intensive Care Med       Date:  2019-02-11       Impact factor: 17.440

Review 2.  Acute kidney injury from sepsis: current concepts, epidemiology, pathophysiology, prevention and treatment.

Authors:  Sadudee Peerapornratana; Carlos L Manrique-Caballero; Hernando Gómez; John A Kellum
Journal:  Kidney Int       Date:  2019-06-07       Impact factor: 10.612

3.  Endotoxin Elimination in Patients with Septic Shock: An Observation Study.

Authors:  Barbara Adamik; Stanislaw Zielinski; Jakub Smiechowicz; Andrzej Kübler
Journal:  Arch Immunol Ther Exp (Warsz)       Date:  2015-06-21       Impact factor: 4.291

4.  Alteco endotoxin hemoadsorption in Gram-negative septic shock patients.

Authors:  Hoi Ping Shum; Yuk Wah Leung; Sin Man Lam; King Chung Chan; Wing Wa Yan
Journal:  Indian J Crit Care Med       Date:  2014-12

5.  Endotoxin hemadsorption in septic shock.

Authors:  Jamshed D Sunavala; Joanne M Mascarenhas
Journal:  Indian J Crit Care Med       Date:  2014-12

Review 6.  Immunomodulation in sepsis: the role of endotoxin removal by polymyxin B-immobilized cartridge.

Authors:  Elisabeth Esteban; Ricard Ferrer; Laia Alsina; Antonio Artigas
Journal:  Mediators Inflamm       Date:  2013-10-22       Impact factor: 4.711

7.  Abdominal Septic Shock - Endotoxin Adsorption Treatment (ASSET) - endotoxin removal in abdominal and urogenital septic shock with the Alteco® LPS Adsorber: study protocol for a double-blinded, randomized placebo-controlled trial.

Authors:  Miklos Lipcsey; Jyrki Tenhunen; Jan Sjölin; Robert Frithiof; Stepani Bendel; Hans Flaatten; Rafael Kawati; Anne Kuitunen; Tor Inge Tønnessen; Sten Rubertsson
Journal:  Trials       Date:  2016-12-08       Impact factor: 2.279

8.  The Use of Endotoxin Adsorption in Extracorporeal Blood Purification Techniques. A Case Report.

Authors:  Adina N Hadade; Caius M Breazu; Iulian V Ilie; Calin I Mitre
Journal:  J Crit Care Med (Targu Mures)       Date:  2017-05-11

Review 9.  Extracorporeal techniques for the treatment of critically ill patients with sepsis beyond conventional blood purification therapy: the promises and the pitfalls.

Authors:  Ghada Ankawi; Mauro Neri; Jingxiao Zhang; Andrea Breglia; Zaccaria Ricci; Claudio Ronco
Journal:  Crit Care       Date:  2018-10-25       Impact factor: 9.097

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.